Redefining the Concept of Standardization for Pluripotent Stem Cells

Stem Cell Reviews and Reports

Volumn 7, Issue 2, 2011, Pages 221-226

  Sengoku, Shintaro ^a   Sumikura, Koichi ^b   Oki, Toshihiko ^c   Nakatsuji, Norio ^a,d  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL GRADUATE INSTITUTE FOR POLICY STUDIES   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Embryonic stem cell; Induced pluripotent stem cell; Intellectual property; Regenerative medicine; Standardization

Indexed keywords

CELL LINE; HUMAN; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT; PATENT; PLURIPOTENT STEM CELL; QUALITY CONTROL; REGENERATIVE MEDICINE; REVIEW; STANDARD; STEM CELL RESEARCH; TRANSPLANTATION;

CELL LINE; HUMANS; INTELLECTUAL PROPERTY; PLURIPOTENT STEM CELLS; PRIVATE SECTOR; QUALITY CONTROL; REFERENCE STANDARDS; REGENERATIVE MEDICINE; STEM CELL RESEARCH;

EID: 79955045006     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9204-8     Document Type: Review

References (17)

1. Loring, J. F., & Rao, M. S. (2006). Establishing standards for the characterization of human embryonic stem cell lines. Stem Cells, 24(1), 145-150.
2. Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., et al. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology, 25, 803-816.
3. Akopian, V., Andrews, P. W., Beil, S., et al. (2010). Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cellular & Developmental Biology - Animal, 46, 247-258.
4. Crook, J. M., Hei, D., Stacey, G. (2010). The International Stem Cell Banking Initiative(ISCBI): raising standards to bank on, In Vitro Cellular and Developmental Biology - Animal, 46, 169-172.
5. Wadman, M. (2007). New tools for drug screening. Nature Reports Stem Cells, doi: 10. 1038/stemcells. 2007. 130.
6. Nakatsuji, N. (2007). Irrational Japanese regulations hinder human embryonic stem cell research. Nature Reports Stem Cells, doi: 10. 1038/stemcells. 2007. 66.
7. Kawakami, M., Sipp, D., & Kato, K. (2010). Regulatory impacts on stem cell research in Japan. Cell Stem Cell, 6(5), 415-418.
8. Takahashi, K., Tanabe, K., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2008). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872.
9. Teece, D. J. (1986). Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy. Research Policy, 15(6), 285-305.
10. Swann, G. M. P. (2000). The economics of standardization: final report for standards and technical regulations directorate. Manchester: University of Manchester Press.
11. Weiss, M., & Cargill, C. (1992). Consortia in the standards development process. Journal of the American Society for Information Science, 43(8), 559-565.
12. Maherali, M., & Hochedlinger, K. (2008). Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell, 3(6), 595-605.
13. Bergman, K., & Graff, G. D. (2007). The global stem cell patent landscape: implications for efficient technology transfer and commercial development. Nature Biotechnology, 25, 419-424.
14. Vrtovec, K. T., & Scott, C. T. (2008). Patenting pluripotence: the next battle for stem cell intellectual property. Nature Biotechnology, 26, 393-395.
15. Asai, Y., Tada, M., Otsuji, G., & Nakatsuji, N. (2010). Combination of functional cardiomyocytes derived from human stem cells and a highly-efficient microelectrode array system: an ideal hybrid model assay for drug development. Current Stem Cell Research & Therapy, 5(3), 227-232.
16. Kim, K., Doi, A., Wen, B., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467, 285-290.
17. Polo, J. M., Liu, S., Figueroa, M. E., et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology, 28, 848-855.